Precision BioSciences (DTIL) to Join Russell Microcap Index

Go back to Precision BioSciences (DTIL) to Join Russell Microcap Index

Precision BioSciences Announces its Addition to the Russell Microcap® Index

July 1, 2024 7:01 AM UTC

DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced its addition to the Russell Microcap® Index. Precisions inclusion in the index follows the conclusion of the 2024 Russell indexes annual reconstitution, which became effective after the close of U.S. markets on June 28, 2024.

"We are pleased to be added to the Index, which highlights our continued progress in advancing our... More